Fundacio Salut i Envelliment UAB Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2013
NCT01915966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Fundacio Salut i Envelliment UAB